Wave Life Sciences WVE Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's accounts payable?
- Wave Life Sciences (WVE) reported accounts payable of $19.06M in Q1 2026.
- How has Wave Life Sciences's accounts payable changed year-over-year?
- Wave Life Sciences's accounts payable increased by 32.8% year-over-year, from $14.36M to $19.06M.
- What is the long-term trend for Wave Life Sciences's accounts payable?
- Over 5 years (2020 to 2025), Wave Life Sciences's accounts payable has grown at a 2.6% compound annual growth rate (CAGR), from $13.8M to $15.7M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.